Ucb Biopharma Srl
Clinical trials sponsored by Ucb Biopharma Srl, explained in plain language.
-
New drug trial aims to ease droopy eyelids and double vision
Disease control Not yet recruitingThis study tests an investigational drug called rozanolixizumab against a placebo in 120 adults with ocular myasthenia gravis, a condition causing eye muscle weakness like droopy eyelids or double vision. The main goal is to see if the drug reduces eye symptoms after about 6 week…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 09, 2026 06:51 UTC
-
New drug shows promise for Long-Term control of rare eye muscle disease
Disease control Not yet recruitingThis study looks at the long-term safety of a drug called rozanolixizumab for adults with ocular myasthenia gravis, a condition that causes muscle weakness in the eyes. About 100 people who have already taken the drug in a previous study will continue treatment. The main goal is …
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
New study tracks rare childhood brain disorder to pave way for future treatments
Knowledge-focused Not yet recruitingThis study follows 60 children with SLC6A1-NDD, a rare genetic condition causing seizures and developmental delays. Researchers will track seizures, behavior, and development over time to better understand the disease. The goal is to prepare for future clinical trials by learning…
Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC